BrainsWay Management
Management criteria checks 3/4
BrainsWay's CEO is Hadar Levy, appointed in Feb 2023, has a tenure of 1.75 years. total yearly compensation is $606.00K, comprised of 55.3% salary and 44.7% bonuses, including company stock and options. directly owns 0.11% of the company’s shares, worth $199.71K. The average tenure of the management team and the board of directors is 1.5 years and 5.4 years respectively.
Key information
Hadar Levy
Chief executive officer
US$606.0k
Total compensation
| CEO salary percentage | 55.3% |
| CEO tenure | 1.8yrs |
| CEO ownership | 0.1% |
| Management average tenure | 1.5yrs |
| Board average tenure | 5.4yrs |
Recent management updates
Recent updates
BrainsWay: Cash Flow Doubts Weigh On The Stock
Nov 13BrainsWay: Operating Leverage Driving Upside
Aug 13BrainsWay: An Interesting Niche Concern
Jul 22BrainsWay: Profitable, Growing, And Cheap
Mar 07BrainsWay Q4 Earnings Preview
Feb 27BrainsWay gets significant private insurance coverage from Cigna for OCD treatment Utilizing Deep TMS
Sep 14BrainsWay adds 20% on FDA nod for depression therapy
Aug 29Brainsway GAAP EPS of -$0.07 in-line, revenue of $8.01M misses by $0.41M
Aug 10BrainsWay's Shares Look Attractive
Jul 12BrainsWay's Competitive Advantage Is Growing
Jan 21BrainsWay: Still Undervalued (Still)
Jun 02BrainsWay gets FDA clearance for Deep TMS protocol in major depressive disorder treatment
Apr 26Brainsway: Still Undervalued
Dec 24Brainsway +4% on Q3 beat, bottom-line up 66%
Nov 18CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$2m |
| Jun 30 2024 | n/a | n/a | US$608k |
| Mar 31 2024 | n/a | n/a | -US$2m |
| Dec 31 2023 | US$606k | US$335k | -US$4m |
| Sep 30 2023 | n/a | n/a | -US$8m |
| Jun 30 2023 | n/a | n/a | -US$13m |
| Mar 31 2023 | n/a | n/a | -US$14m |
| Dec 31 2022 | US$551k | US$412k | -US$13m |
| Sep 30 2022 | n/a | n/a | -US$11m |
| Jun 30 2022 | n/a | n/a | -US$8m |
| Mar 31 2022 | n/a | n/a | -US$7m |
| Dec 31 2021 | US$824k | US$443k | -US$6m |
| Sep 30 2021 | n/a | n/a | -US$6m |
| Jun 30 2021 | n/a | n/a | -US$5m |
| Mar 31 2021 | n/a | n/a | -US$5m |
| Dec 31 2020 | US$502k | US$280k | -US$5m |
| Sep 30 2020 | n/a | n/a | -US$7m |
| Jun 30 2020 | n/a | n/a | -US$9m |
| Mar 31 2020 | n/a | n/a | -US$12m |
| Dec 31 2019 | US$590k | US$372k | -US$10m |
| Sep 30 2019 | n/a | n/a | -US$10m |
| Jun 30 2019 | n/a | n/a | -US$9m |
| Mar 31 2019 | n/a | n/a | -US$7m |
| Dec 31 2018 | US$325k | US$155k | -US$6m |
Compensation vs Market: Hadar's total compensation ($USD606.00K) is below average for companies of similar size in the US market ($USD1.48M).
Compensation vs Earnings: Hadar's compensation has been consistent with company performance over the past year.
CEO
Hadar Levy (50 yo)
1.8yrs
Tenure
US$606,000
Compensation
Mr. Hadar Levy serves as Director of Lifeward Ltd. (formerly known as ReWalk Robotics Ltd.) since August 03, 2022. He serves as Chief Executive Officer at BrainsWay Ltd.since February 13, 2023 and served...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 1.8yrs | US$606.00k | 0.11% $ 199.7k | |
| Founder & Director | 18.8yrs | US$43.65k | 5.51% $ 10.2m | |
| Co-Founder | no data | US$72.18k | 2.49% $ 4.6m | |
| Founder & Chief Scientific Officer | 18.5yrs | US$108.00k | 2.9% $ 5.4m | |
| Chief Financial Officer | 1.5yrs | no data | 0% $ 0 | |
| Chief Technology Officer | less than a year | no data | no data | |
| VP, General Counsel & Corporate Secretary | 11.8yrs | no data | no data | |
| Vice President of Global Marketing | less than a year | no data | no data | |
| Vice President of International Sales | less than a year | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data |
1.5yrs
Average Tenure
53.5yo
Average Age
Experienced Management: BWAY's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Director | 18.8yrs | US$43.65k | 5.51% $ 10.2m | |
| Co-Founder | 5.4yrs | US$72.18k | 2.49% $ 4.6m | |
| Independent Director | 6.9yrs | US$56.99k | 0% $ 0 | |
| Independent Director | 5.9yrs | US$42.12k | 0.78% $ 1.5m | |
| Independent Chairman | 1.8yrs | US$147.87k | 0% $ 0 | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Co-Founder & Vice-Chairman | 1.8yrs | US$35.79k | 5.74% $ 10.6m | |
| Independent Director | 8.4yrs | US$58.66k | 0% $ 0 | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 4.8yrs | US$55.61k | 0% $ 0 | |
| Member of the Scientific Advisory Board | 3.1yrs | no data | no data |
5.4yrs
Average Tenure
63yo
Average Age
Experienced Board: BWAY's board of directors are considered experienced (5.4 years average tenure).